BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 7003562)

  • 1. Adjuvant chemotherapy of breast cancer. National Institutes of Health Consensus Development Conference Summary, Volume 3, Number 3.
    Oncol Nurs Forum; 1981; 8(1):7-9. PubMed ID: 7003562
    [No Abstract]   [Full Text] [Related]  

  • 2. NIH Consensus Development Conference summary: Adjuvant Chemotherapy of Breast Cancer.
    J Tenn Med Assoc; 1981 Mar; 74(3):190-2. PubMed ID: 7024644
    [No Abstract]   [Full Text] [Related]  

  • 3. Adjuvant chemotherapy for breast cancer. National Institutes of Health Consensus Development Conference Statement.
    Natl Inst Health Consens Dev Conf Consens Statement; 1985; 5(12):5 p.. PubMed ID: 3908920
    [No Abstract]   [Full Text] [Related]  

  • 4. NIH consensus-development statement. Adjuvant chemotherapy of breast cancer. The NIH Consensus-Development Panel.
    N Engl J Med; 1980 Oct; 303(14):831-2. PubMed ID: 6997737
    [No Abstract]   [Full Text] [Related]  

  • 5. National Institutes of Health Consensus Development Conference statement: adjuvant therapy for breast cancer, November 1-3, 2000.
    National Institutes of Health Consensus Development Panel
    J Natl Cancer Inst Monogr; 2001; (30):5-15. PubMed ID: 11773285
    [TBL] [Abstract][Full Text] [Related]  

  • 6. NCI's breast cancer clinical alert: rationale and results.
    DeVita VT; Hubbard SM
    Resid Staff Physician; 1989 Jul; 35(8):49-55. PubMed ID: 10303742
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Consensus conference 2000: adjuvant therapy for breast cancer. National Institutes of Health Consensus Development Conference Statement November 1-3, 2000.
    Cancer Control; 2001; 8(1):55. PubMed ID: 11176036
    [No Abstract]   [Full Text] [Related]  

  • 8. Breast conservation therapy in the United States following the 1990 National Institutes of Health Consensus Development Conference on the treatment of patients with early stage invasive breast carcinoma.
    Lazovich D; Solomon CC; Thomas DB; Moe RE; White E
    Cancer; 1999 Aug; 86(4):628-37. PubMed ID: 10440690
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy of breast cancer. Sponsored by the National Cancer Institute, assisted by the Office for Medical Applications of Research, NIH.
    Conn Med; 1980 Nov; 44(11):721-3. PubMed ID: 7226778
    [No Abstract]   [Full Text] [Related]  

  • 10. Some thoughts on the future of clinical trials in cancer.
    Wittes RE; Friedman MA; Simon R
    Cancer Treat Rep; 1986 Feb; 70(2):241-50. PubMed ID: 2418968
    [No Abstract]   [Full Text] [Related]  

  • 11. [A United States National Institutes of Health investigation suspended due to risk of breast cancer with use of hormone replacement in menopause].
    Zárate-Treviño A
    Gac Med Mex; 2002; 138(6):595-6. PubMed ID: 12532629
    [No Abstract]   [Full Text] [Related]  

  • 12. Cancer institute to tighten control of trials.
    Gavaghan H
    Nature; 1994 Apr; 368(6473):679. PubMed ID: 8152474
    [No Abstract]   [Full Text] [Related]  

  • 13. National Institutes of Health Consensus Development Conference on Adjuvant Chemotherapy and Endocrine Therapy for Breast Cancer. Bethesda, Maryland, September 9-11, 1985.
    NCI Monogr; 1986; (1):1-159. PubMed ID: 3774009
    [No Abstract]   [Full Text] [Related]  

  • 14. Review of breast cancer clinical trials conducted by the National Surgical Adjuvant Breast Project.
    Newman LA; Mamounas EP
    Surg Clin North Am; 2007 Apr; 87(2):279-305, vii. PubMed ID: 17498527
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cancer treatment clinical trials--DoD. Notice of demonstration project.
    Fed Regist; 1996 Jan; 61(16):1899-900. PubMed ID: 10154406
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The "clinical alert" from the National Cancer Institute.
    Lee KC
    N Engl J Med; 1988 Oct; 319(14):948-9. PubMed ID: 3419459
    [No Abstract]   [Full Text] [Related]  

  • 17. Clinical trials Referral Resource. Clinical trials at the medicine branch of the NCI--Part I.
    Cheson BD; Wittes RE; Phillips PH
    Oncology (Williston Park); 1995 Apr; 9(4):292-4. PubMed ID: 7547193
    [No Abstract]   [Full Text] [Related]  

  • 18. Evaluating promising new treatments for life-threatening disease: implications of the HDC/ABMT experience for treating breast cancer.
    Edwards S
    Find Brief; 2005 Jan; 8(1):1-3. PubMed ID: 15672527
    [No Abstract]   [Full Text] [Related]  

  • 19. Trials 'must compete for new funds'.
    Gavaghan H
    Nature; 1994 Jun; 369(6482):597. PubMed ID: 8208276
    [No Abstract]   [Full Text] [Related]  

  • 20. Adjuvant therapy for breast cancer.
    NIH Consens Statement; 2000 Nov 1-3; 17(4):1-35. PubMed ID: 11512506
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.